Clinical trial
Islet Cell Transplants for Diabetes
NCT00303134 · Weill Medical College of Cornell University, Other · Terminated
Key facts
| NCT number | NCT00303134 |
|---|---|
| Title | Islet Cell Transplants for Diabetes |
| Official title | Human Islet Cell Transplantation in Type 1 Diabetic Patients |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Islet Cell Transplantation |
| Enrollment | 3 |
| Start date | Aug 1, 2003 |
| Primary completion | Oct 23, 2007 |
| Completion | Jun 24, 2010 |
| First posted | Mar 15, 2006 |
| Last update posted | Jun 3, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: